MoneyWorks4Me

Parabolic Drugs informs about standalone financial results

10 Feb 2017 Evaluate

Parabolic Drugs has informed about Standalone Financial Results & Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..